三個皮匠報告
政策庫
new
付費
搜索

國內IL-1β靶點藥物競爭格局（IND及以上）-行業數據

國內IL-1β靶點藥物競爭格局（IND及以上）
國內IL-1β靶點藥物競爭格局（IND及以上）
SSGJ-613 是一款 IL-1β單抗，針對急性痛風性關節炎，患者基數大，市場競爭格局良好。目前國內尚無自主針對 IL-1β的單抗上市，存在大量未被滿足的醫療需求。613 已完成臨床 III 期所有受試者入組，在同類靶點藥物的研究進程中處于第一梯隊。
競爭格局 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?20KB 圖片尺寸：2302*454
同報告圖片
 / 43
國內IL-1β靶點藥物競爭格局（IND及以上）_第1頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第2頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第3頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第4頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第5頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第6頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第7頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第8頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第9頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第10頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第11頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第12頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第13頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第14頁
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOiNr+WTgeWQjeensCB8IOS9nOeUqOacuuWItiB8IOeglOWPkeacuuaehCB8IOeWvueXhSB8IOS4reWbvemYtuautSB8IOS4reWbveaXpeacnyB8IOe+juWbvemYtuautSB8IOe+juWbveaXpeacnyB8CnwtLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCDkvp3msoPopb/ljZXmipcgfCBQREwxL1ZFR0Yg5Y+M5oqXIHwgU3VtbWl0O+W6t+aWueeUn+eJqSjljp/noJQpIHwg6Z2e5bCP57uG6IOe6IK655mMO+WktOmiiOmDqOmznueKtue7huiDnueZjDvkuInpmLTmgKfkubPohbrnmYznrYkgfCDmibnlh4bkuIrluIIgfCAyMDI0LTA1LTIxIHwgSUlJ5pyf5Li05bqKIHwgMjAyMy0wNi0xMiB8CnwgUE04MDAyIHwgUERMMS9WRUdGIOWPjOaKlyB8IEJpb05UZWNoO+aZruexs+aWryjljp/noJQpIHwg5LiJ6Zi05oCn5Lmz6IW655mMO+Wwj+e7huiDnuiCuueZjDvpnZ7lsI/nu4bog57ogrrnmYznrYkgfCBJSUnmnJ/kuLTluoogfCAyMDI0LTA1LTA2IHwgSUlJ5pyf5Li05bqKIHwgMjAyNC0wNi0wNyB8CnwgUkMxNDggfCBQREwxL1ZFR0Yg5Y+M5oqXIHwg6I2j5piM55Sf54mpKOWOn+eglCkgfCBIRVIyIOS9juihqOi+vuS5s+iFuueZjOetiSB8IElJ5pyf5Li05bqKIHwgMjAyNC0wOS0zMCB8IOS4tOW6iuWJjSB8IDIwMjQtMDktMzAgfAp8IHNvdGliYXR1cWltYWIgYWxmYSB8IFBETDEvVkVHRiDlj4zmipcgfCDljY7ljZrnlJ/niako5Y6f56CUKSB8IOiCvue7huiDnueZjDvpnZ7lsI/nu4bog57ogrrnmYznrYkgfCBJSeacn+S4tOW6iiB8IDIwMjItMTEtMDQgfCBJ5pyf5Li05bqKIHwgMjAyMC0xMi0yMiB8CnwgQVA1MDUgfCBQREwxL1ZFR0Yg5Y+M5oqXIHwg5Y2O5ram5LiJ5LmdO+WchuelpeeUn+WRveenkeaKgCjljp/noJQpIHwg5a6e5L2T55ik562JIHwgSUnmnJ/kuLTluoogfCAyMDI0LTA4LTE0IHwg5Li05bqK5YmNIHwgMjAyNC0wOC0xNCB8CnwgSU1NMjUxMCB8IFBETDEvVkVHRiDlj4zmipcgfCBJbnN0aWwgQmlvO+WunOaYjuaYguenkSjljp/noJQpIHwg6L2v57uE57uH6IKJ55ikO+mdnuWwj+e7huiDnuiCuueZjDvkuInpmLTmgKfkubPohbrnmYznrYkgfCBJSeacn+S4tOW6iiB8IDIwMjMtMTEtMjAgfCDkuLTluorliY0gfCAyMDIzLTExLTIwIHwKfCBTU0dKLTcwNyB8IFBETDEvVkVHRiDlj4zmipcgfCDkuInnlJ/liLboja875LiJ55Sf5Zu95YGlKOWOn+eglCkgfCDpnZ7lsI/nu4bog57ogrrnmYw757uT55u06IKg55mMO+WNteW3oueZjOetiSB8IElJ5pyf5Li05bqKIHwgMjAyNC0wMS0yNCB8IOS4tOW6iuWJjSB8IDIwMjQtMDEtMjQgfAp8IE1IQjAzOUEgfCBQREwxL1ZFR0Yg5Y+M5oqXIHwg5piO5oWn5Yy76I2vKOWOn+eglCkgfCDlrp7kvZPnmKQ76IK655mMIHwgSUlJ5pyf5Li05bqKIHwgMjAyMy0xMi0yNiB8IOS4tOW6iuWJjSB8IDIwMjMtMTItMjYgfAp8IFNDVEIxNCB8IFBETDEvVkVHRiDlj4zmipcgfCDnpZ7lt57nu4bog54o5Y6f56CUKSB8IOWunuS9k+eYpCB8IElJSeacn+S4tOW6iiB8IDIwMjQtMDQtMjYgfCDkuLTluorliY0gfCAyMDI0LTA0LTI2IHwKfCBMTS0yOTkgfCBQREwxL1ZFR0Yg5Y+M5oqXIHwgTWVyY2sgJiBDby4756S85paw5Yy76I2vKOWOn+eglCkgfCDlrp7kvZPnmKQgfCBJSUnmnJ/kuLTluoogfCAyMDI0LTA5LTE0IHwg5Li05bqK5YmNIHwgMjAyNC0wOS0xNCB8CnwgUE04MDAzIHwgUERMMS9WRUdGL1RHRi3OsiDkuInmipcgfCDmma7nsbPmlq8oQmlvTlRlY2gpKOWOn+eglCkgfCDlrp7kvZPnmKQgfCBJSUnmnJ/kuLTluoogfCAyMDIxLTA3LTMwIHwg5Li05bqK5YmNIHwgMjAyMS0wNy0zMCB8CnwgRFIzMDIwNiB8IFBETDEvVEdGLc6yL1ZFR0Yg5LiJ5oqXIHwg6YGT5bCU55Sf54mpKOWOn+eglCkgfCDlrp7kvZPnmKQgfCBJ5pyf5Li05bqKIHwgMjAyMy0xMS0xNSB8IOS4tOW6iuWJjSB8IDIwMjMtMTEtMTUgfAp8IEpTMjA3IHwgUERMMS9WRUdGIOWPjOaKlyB8IERvdEJpbzvlkJvlrp7nlJ/niako5Y6f56CUKSB8IOeZjOeXhzvogr/nmKQgfCBJ5pyf5Li05bqKIHwgMjAyMy0wOS0wMSB8IOS4tOW6iuWJjSB8IDIwMjMtMDktMDEgfAp8IFNHMTQwOCB8IFBETDEvVkVHRiDlj4zmipcgfCDlsJrlgaXnlJ/niako5Y6f56CUKSB8IOWunuS9k+eYpCB8IEnmnJ/kuLTluoogfCAyMDIyLTExLTAyIHwg5Li05bqK5YmNIHwgMjAyMi0xMS0wMiB8CnwgQ1ZMMDA2IHwgUERMMS9WRUdGIOWPjOaKlyB8IOiCsuW6t+iNr+S4mijljp/noJQpIHwg5a6e5L2T55ikIHwgSeacn+S4tOW6iiB8IDIwMjQtMDktMDIgfCDkuLTluorliY0gfCAyMDI0LTA5LTAyIHwKfCBIQzAxMCB8IFBETDEvQ1RMQTQvVkVHRiDkuInmipcgfCDlro/miJDljLvoja8o5Y6f56CUKSB8IOWunuS9k+eYpOetiSB8IEnmnJ/kuLTluoogfCAyMDI0LTAyLTIwIHwg5Li05bqK5YmNIHwgMjAyNC0wMi0yMCB8CnwgQUktMDgxIHwgUERMMS9WRUdGIOWPjOaKlyB8IE9uY29DQSjljp/noJQ=
國內IL-1β靶點藥物競爭格局（IND及以上）_第15頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第16頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第17頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第18頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第19頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第20頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第21頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第22頁
fOiCoeS4nOWQjeensCB85oyB6IKh5q+U5L6LIHwKfC0tLXwtLS18CnzlqITnq54gfDIuMTIlIHwKfERlY2FkZSBTdW5zaGluZSBMaW1pdGVkIHwxOS43MyUgfAp8VE1GIChDYXltYW4pIEx0ZC4gfDIzLjg4JSB8Cnzoi4/lhqzmooUgfDEuMDElIHwKfOiBlOi9qembhuWbouaciemZkOWFrOWPuCB8NS4xMyUgfAp8QmxhY2sgUm9jaywgSW5jLiB8MC41MyUgfAp85byg5aej5ailIHwwLjUzJSB8
國內IL-1β靶點藥物競爭格局（IND及以上）_第23頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第24頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第25頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第26頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第27頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第28頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第29頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第30頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第31頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第32頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第33頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第34頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第35頁
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
國內IL-1β靶點藥物競爭格局（IND及以上）_第36頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第37頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第38頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第39頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第40頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第41頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第42頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第43頁
國內IL-1β靶點藥物競爭格局（IND及以上）_第44頁
所屬報告： 三生制藥-港股公司研究報告-核心品種穩健增長創新管線邁入收獲期-250217（35頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站